Wordt geladen...
Therapeutically targeting guanylate cyclase‐C: computational modeling of plecanatide, a uroguanylin analog
Plecanatide is a recently developed guanylate cyclase‐C (GC‐C) agonist and the first uroguanylin analog designed to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS‐C). GC‐C receptors are found across the length of the intestines and are thought to play...
Bewaard in:
| Gepubliceerd in: | Pharmacol Res Perspect |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5368960/ https://ncbi.nlm.nih.gov/pubmed/28357122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.295 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|